Jinwu Financial News | Global Healthcare (02666) announced that for the year ended December 31, 2023, the company's common equity holders should account for the annual profit of about RMB 2,021 billion (RMB, same below), an increase of 7.0% over the previous year; basic earnings per share were 1.07 yuan, compared with 1 yuan for the same period last year. A proposed final dividend of HK$0.35 per common share.
During the period, revenue was approximately RMB 13.65 billion, an increase of 13.1% over the previous year. Among them, the healthcare business revenue was about 7.833 billion yuan, an increase of 22.9% over 2022, and the share of total revenue increased to 57.4%.
During the period, the company achieved gross profit of 4.572 billion yuan, an increase of 1.73% over the previous year.
During the period, the company's R&D expenses were 35.875 million yuan, a year-on-year decrease of 25.37%.